Study: Human blood antibody relieves chronic pain condition

02/1/2010 | National Post (Canada)

U.K. scientists found that almost half of 13 patients with complex regional pain syndrome experienced pain relief for an average of five weeks after receiving a low-dose transfusion of intravenous immunoglobulin, a human blood antibody. "The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions," the lead researcher said.

View Full Article in:

National Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA